In early September, Alpha Tau announced that it treated the first patient in its 30-patient US trial. This trial is set to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback